ACP Internist February 2016
-
Changes, challenges in treating heart failure
Readmissions among heart failure patients can be prevented with diligent, evidence-based primary care. But with their time at a premium, physicians can be increasingly concerned about meeting the needs of this population. -
HPV vaccine efficacy increases, but use lags
Human papillomavirus immunization rates continue, for several reasons, to lag behind those of other vaccines. Experts are formulating new approaches for physicians and patients to ensure that HPV protection is as robust as possible. -
Weighing the risks of valproate for epilepsy in women
Valproate may sometimes be the only treatment option for epilepsy in women of childbearing age. An expert explains how to handle the issue.
ACP Hospitalist February 2016
-
Building new stroke systems
Now that endovascular therapy has been officially endorsed by experts, how should hospitals respond? -
Reversal agents for the direct oral anticoagulants
New class more likely to be used for reassurance than treatment, experts say. -
Optimizing heart failure medications at discharge
Guidelines, nonadherence, interactions, and transitions make for tricky balance. -
Antibiotics may carry more cost than benefit for patients at end of life
Experts offer advice on discussing and deciding when to use or avoid.
Back to March International Newsletter